Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses
In vitro photosensitivity of rapamycin (RAPA) and ocular toxicity and distribution of intravitreal and subconjunctival RAPA was evaluated in normal horses. RAPA (2.5 mg, 5 mg, and 10 mg) was placed in 10 mL of PBS and maintained in a water bath at 37 °C, kept in the dark or subjected to room light,...
Gespeichert in:
Veröffentlicht in: | Journal of veterinary pharmacology and therapeutics 2008-12, Vol.31 (6), p.511-516 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 516 |
---|---|
container_issue | 6 |
container_start_page | 511 |
container_title | Journal of veterinary pharmacology and therapeutics |
container_volume | 31 |
creator | DOUGLAS, L.C YI, N.Y DAVIS, J.L SALMON, J.H GILGER, B.C |
description | In vitro photosensitivity of rapamycin (RAPA) and ocular toxicity and distribution of intravitreal and subconjunctival RAPA was evaluated in normal horses. RAPA (2.5 mg, 5 mg, and 10 mg) was placed in 10 mL of PBS and maintained in a water bath at 37 °C, kept in the dark or subjected to room light, and sampled for up to 3 months for RAPA levels. Six normal adult horses received either 5 mg (n = 2) or 10 mg (n = 2) of RAPA intravitreally or 10 mg (n = 2) subconjunctivally. Ophthalmic exams and electroretinography (ERG) were performed prior to injection and on days 1, 7, 14, and 21 post-injection. Eyes were enucleated and samples were collected for RAPA concentrations and histopathology. No difference in light vs. dark RAPA concentrations was observed, suggesting a lack of RAPA phototoxicity. No evidence of ocular toxicity was noted on ophthalmic examination or histopathology. RAPA was not detected intraocularly 7 days post-injection in eyes receiving subconjunctival RAPA, but was detected in the vitreous at 21 days post-injection. Drug could be detected in both the aqueous and vitreous humor after intravitreal injection. Further study is needed to determine the efficacy of intravitreal RAPA. |
doi_str_mv | 10.1111/j.1365-2885.2008.00986.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_745633637</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>745633637</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4606-8bd7d5fe0491d012878d75772582b45b321c99eb610196aba95074c247ab60773</originalsourceid><addsrcrecordid>eNqNkE1v1DAQhi0EokvhL0BunBLGdvwRiQutaEspFAkK3CzbccBLNl7spOz-e5xmVa7MZUbj5x1LD0IFhgrnerWuMOWsJFKyigDICqCRvNo9QKv7h4doBbiGUghJj9CTlNYAQCXGj9ERbvJMBFmh79d26nUsxrDz1o_7Qg9t0fo0Rm-m0YehCF2RJmPDsJ4GO_pb3d8xfhijvvVjdHkR9VZv9tYPeV38DDG59BQ96nSf3LNDP0Y3Z2-_nF6UV9fn707fXJW25sBLaVrRss5B3eAWMJFCtoIJQZgkpmaGEmybxhmOATdcG90wELUltdCGgxD0GL1c7m5j-D25NKqNT9b1vR5cmJISNeOUcjqTciFtDClF16lt9Bsd9wqDmrWqtZrtqdmemrWqO61ql6PPD59MZuPaf8GDxwy8XoA_vnf7_z6sLr9-ykOOl0s8i3e7-7iOvxQXVDD17eO5en_GL0_4xQd1kvkXC9_poPSP6JO6-UwAU8CMQ1NL-hcqSZ6L</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>745633637</pqid></control><display><type>article</type><title>Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>DOUGLAS, L.C ; YI, N.Y ; DAVIS, J.L ; SALMON, J.H ; GILGER, B.C</creator><creatorcontrib>DOUGLAS, L.C ; YI, N.Y ; DAVIS, J.L ; SALMON, J.H ; GILGER, B.C</creatorcontrib><description>In vitro photosensitivity of rapamycin (RAPA) and ocular toxicity and distribution of intravitreal and subconjunctival RAPA was evaluated in normal horses. RAPA (2.5 mg, 5 mg, and 10 mg) was placed in 10 mL of PBS and maintained in a water bath at 37 °C, kept in the dark or subjected to room light, and sampled for up to 3 months for RAPA levels. Six normal adult horses received either 5 mg (n = 2) or 10 mg (n = 2) of RAPA intravitreally or 10 mg (n = 2) subconjunctivally. Ophthalmic exams and electroretinography (ERG) were performed prior to injection and on days 1, 7, 14, and 21 post-injection. Eyes were enucleated and samples were collected for RAPA concentrations and histopathology. No difference in light vs. dark RAPA concentrations was observed, suggesting a lack of RAPA phototoxicity. No evidence of ocular toxicity was noted on ophthalmic examination or histopathology. RAPA was not detected intraocularly 7 days post-injection in eyes receiving subconjunctival RAPA, but was detected in the vitreous at 21 days post-injection. Drug could be detected in both the aqueous and vitreous humor after intravitreal injection. Further study is needed to determine the efficacy of intravitreal RAPA.</description><identifier>ISSN: 0140-7783</identifier><identifier>EISSN: 1365-2885</identifier><identifier>DOI: 10.1111/j.1365-2885.2008.00986.x</identifier><identifier>PMID: 19000272</identifier><language>eng</language><publisher>Oxford, UK: Oxford, UK : Blackwell Publishing Ltd</publisher><subject>Animals ; Anti-Bacterial Agents - adverse effects ; Anti-Bacterial Agents - pharmacokinetics ; Anti-Bacterial Agents - therapeutic use ; antibiotics ; aqueous humor ; chemical concentration ; Chromatography, High Pressure Liquid ; conjunctiva ; Dermatitis, Phototoxic ; dosage ; drug evaluation ; drug injection ; drug toxicity ; electroretinography ; eyes ; histopathology ; Horses ; intravitreal injection ; pharmacokinetics ; photostability ; Sirolimus - adverse effects ; Sirolimus - pharmacokinetics ; Sirolimus - therapeutic use ; subconjunctival injection ; Tissue Distribution ; Uveitis - drug therapy ; Uveitis - veterinary ; vitreous humor</subject><ispartof>Journal of veterinary pharmacology and therapeutics, 2008-12, Vol.31 (6), p.511-516</ispartof><rights>2008 The Authors. Journal compilation © 2008 Blackwell Publishing Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4606-8bd7d5fe0491d012878d75772582b45b321c99eb610196aba95074c247ab60773</citedby><cites>FETCH-LOGICAL-c4606-8bd7d5fe0491d012878d75772582b45b321c99eb610196aba95074c247ab60773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2885.2008.00986.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2885.2008.00986.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19000272$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DOUGLAS, L.C</creatorcontrib><creatorcontrib>YI, N.Y</creatorcontrib><creatorcontrib>DAVIS, J.L</creatorcontrib><creatorcontrib>SALMON, J.H</creatorcontrib><creatorcontrib>GILGER, B.C</creatorcontrib><title>Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses</title><title>Journal of veterinary pharmacology and therapeutics</title><addtitle>J Vet Pharmacol Ther</addtitle><description>In vitro photosensitivity of rapamycin (RAPA) and ocular toxicity and distribution of intravitreal and subconjunctival RAPA was evaluated in normal horses. RAPA (2.5 mg, 5 mg, and 10 mg) was placed in 10 mL of PBS and maintained in a water bath at 37 °C, kept in the dark or subjected to room light, and sampled for up to 3 months for RAPA levels. Six normal adult horses received either 5 mg (n = 2) or 10 mg (n = 2) of RAPA intravitreally or 10 mg (n = 2) subconjunctivally. Ophthalmic exams and electroretinography (ERG) were performed prior to injection and on days 1, 7, 14, and 21 post-injection. Eyes were enucleated and samples were collected for RAPA concentrations and histopathology. No difference in light vs. dark RAPA concentrations was observed, suggesting a lack of RAPA phototoxicity. No evidence of ocular toxicity was noted on ophthalmic examination or histopathology. RAPA was not detected intraocularly 7 days post-injection in eyes receiving subconjunctival RAPA, but was detected in the vitreous at 21 days post-injection. Drug could be detected in both the aqueous and vitreous humor after intravitreal injection. Further study is needed to determine the efficacy of intravitreal RAPA.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>antibiotics</subject><subject>aqueous humor</subject><subject>chemical concentration</subject><subject>Chromatography, High Pressure Liquid</subject><subject>conjunctiva</subject><subject>Dermatitis, Phototoxic</subject><subject>dosage</subject><subject>drug evaluation</subject><subject>drug injection</subject><subject>drug toxicity</subject><subject>electroretinography</subject><subject>eyes</subject><subject>histopathology</subject><subject>Horses</subject><subject>intravitreal injection</subject><subject>pharmacokinetics</subject><subject>photostability</subject><subject>Sirolimus - adverse effects</subject><subject>Sirolimus - pharmacokinetics</subject><subject>Sirolimus - therapeutic use</subject><subject>subconjunctival injection</subject><subject>Tissue Distribution</subject><subject>Uveitis - drug therapy</subject><subject>Uveitis - veterinary</subject><subject>vitreous humor</subject><issn>0140-7783</issn><issn>1365-2885</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1v1DAQhi0EokvhL0BunBLGdvwRiQutaEspFAkK3CzbccBLNl7spOz-e5xmVa7MZUbj5x1LD0IFhgrnerWuMOWsJFKyigDICqCRvNo9QKv7h4doBbiGUghJj9CTlNYAQCXGj9ERbvJMBFmh79d26nUsxrDz1o_7Qg9t0fo0Rm-m0YehCF2RJmPDsJ4GO_pb3d8xfhijvvVjdHkR9VZv9tYPeV38DDG59BQ96nSf3LNDP0Y3Z2-_nF6UV9fn707fXJW25sBLaVrRss5B3eAWMJFCtoIJQZgkpmaGEmybxhmOATdcG90wELUltdCGgxD0GL1c7m5j-D25NKqNT9b1vR5cmJISNeOUcjqTciFtDClF16lt9Bsd9wqDmrWqtZrtqdmemrWqO61ql6PPD59MZuPaf8GDxwy8XoA_vnf7_z6sLr9-ykOOl0s8i3e7-7iOvxQXVDD17eO5en_GL0_4xQd1kvkXC9_poPSP6JO6-UwAU8CMQ1NL-hcqSZ6L</recordid><startdate>200812</startdate><enddate>200812</enddate><creator>DOUGLAS, L.C</creator><creator>YI, N.Y</creator><creator>DAVIS, J.L</creator><creator>SALMON, J.H</creator><creator>GILGER, B.C</creator><general>Oxford, UK : Blackwell Publishing Ltd</general><general>Blackwell Publishing Ltd</general><scope>FBQ</scope><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>200812</creationdate><title>Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses</title><author>DOUGLAS, L.C ; YI, N.Y ; DAVIS, J.L ; SALMON, J.H ; GILGER, B.C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4606-8bd7d5fe0491d012878d75772582b45b321c99eb610196aba95074c247ab60773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>antibiotics</topic><topic>aqueous humor</topic><topic>chemical concentration</topic><topic>Chromatography, High Pressure Liquid</topic><topic>conjunctiva</topic><topic>Dermatitis, Phototoxic</topic><topic>dosage</topic><topic>drug evaluation</topic><topic>drug injection</topic><topic>drug toxicity</topic><topic>electroretinography</topic><topic>eyes</topic><topic>histopathology</topic><topic>Horses</topic><topic>intravitreal injection</topic><topic>pharmacokinetics</topic><topic>photostability</topic><topic>Sirolimus - adverse effects</topic><topic>Sirolimus - pharmacokinetics</topic><topic>Sirolimus - therapeutic use</topic><topic>subconjunctival injection</topic><topic>Tissue Distribution</topic><topic>Uveitis - drug therapy</topic><topic>Uveitis - veterinary</topic><topic>vitreous humor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DOUGLAS, L.C</creatorcontrib><creatorcontrib>YI, N.Y</creatorcontrib><creatorcontrib>DAVIS, J.L</creatorcontrib><creatorcontrib>SALMON, J.H</creatorcontrib><creatorcontrib>GILGER, B.C</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Journal of veterinary pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DOUGLAS, L.C</au><au>YI, N.Y</au><au>DAVIS, J.L</au><au>SALMON, J.H</au><au>GILGER, B.C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses</atitle><jtitle>Journal of veterinary pharmacology and therapeutics</jtitle><addtitle>J Vet Pharmacol Ther</addtitle><date>2008-12</date><risdate>2008</risdate><volume>31</volume><issue>6</issue><spage>511</spage><epage>516</epage><pages>511-516</pages><issn>0140-7783</issn><eissn>1365-2885</eissn><abstract>In vitro photosensitivity of rapamycin (RAPA) and ocular toxicity and distribution of intravitreal and subconjunctival RAPA was evaluated in normal horses. RAPA (2.5 mg, 5 mg, and 10 mg) was placed in 10 mL of PBS and maintained in a water bath at 37 °C, kept in the dark or subjected to room light, and sampled for up to 3 months for RAPA levels. Six normal adult horses received either 5 mg (n = 2) or 10 mg (n = 2) of RAPA intravitreally or 10 mg (n = 2) subconjunctivally. Ophthalmic exams and electroretinography (ERG) were performed prior to injection and on days 1, 7, 14, and 21 post-injection. Eyes were enucleated and samples were collected for RAPA concentrations and histopathology. No difference in light vs. dark RAPA concentrations was observed, suggesting a lack of RAPA phototoxicity. No evidence of ocular toxicity was noted on ophthalmic examination or histopathology. RAPA was not detected intraocularly 7 days post-injection in eyes receiving subconjunctival RAPA, but was detected in the vitreous at 21 days post-injection. Drug could be detected in both the aqueous and vitreous humor after intravitreal injection. Further study is needed to determine the efficacy of intravitreal RAPA.</abstract><cop>Oxford, UK</cop><pub>Oxford, UK : Blackwell Publishing Ltd</pub><pmid>19000272</pmid><doi>10.1111/j.1365-2885.2008.00986.x</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0140-7783 |
ispartof | Journal of veterinary pharmacology and therapeutics, 2008-12, Vol.31 (6), p.511-516 |
issn | 0140-7783 1365-2885 |
language | eng |
recordid | cdi_proquest_miscellaneous_745633637 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Animals Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - pharmacokinetics Anti-Bacterial Agents - therapeutic use antibiotics aqueous humor chemical concentration Chromatography, High Pressure Liquid conjunctiva Dermatitis, Phototoxic dosage drug evaluation drug injection drug toxicity electroretinography eyes histopathology Horses intravitreal injection pharmacokinetics photostability Sirolimus - adverse effects Sirolimus - pharmacokinetics Sirolimus - therapeutic use subconjunctival injection Tissue Distribution Uveitis - drug therapy Uveitis - veterinary vitreous humor |
title | Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T08%3A52%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ocular%20toxicity%20and%20distribution%20of%20subconjunctival%20and%20intravitreal%20rapamycin%20in%20horses&rft.jtitle=Journal%20of%20veterinary%20pharmacology%20and%20therapeutics&rft.au=DOUGLAS,%20L.C&rft.date=2008-12&rft.volume=31&rft.issue=6&rft.spage=511&rft.epage=516&rft.pages=511-516&rft.issn=0140-7783&rft.eissn=1365-2885&rft_id=info:doi/10.1111/j.1365-2885.2008.00986.x&rft_dat=%3Cproquest_cross%3E745633637%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=745633637&rft_id=info:pmid/19000272&rfr_iscdi=true |